Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
PZ HTL SA

Live Images of Growing Tumors Reveals Cancer’s Hidden Mechanisms

By BiotechDaily International staff writers
Posted on 25 Sep 2013
Image: The new imaging tool reveals strikingly different networks of blood vessels surrounding different types of tumors in a mouse model. Left: breast cancer in the breast. Middle: metastatic breast cancer in the brain. Right: ectopic breast cancer in the skin (Photo courtesy of Nature Medicine).
Image: The new imaging tool reveals strikingly different networks of blood vessels surrounding different types of tumors in a mouse model. Left: breast cancer in the breast. Middle: metastatic breast cancer in the brain. Right: ectopic breast cancer in the skin (Photo courtesy of Nature Medicine).
Image: A tumor before (left) and five days after (right) anti-angiogenic treatment--a novel treatment approach by inhibiting blood vessel growth skin (Photo courtesy of Nature Medicine).
Image: A tumor before (left) and five days after (right) anti-angiogenic treatment--a novel treatment approach by inhibiting blood vessel growth skin (Photo courtesy of Nature Medicine).
A group of researchers has developed a novel new optical imaging tool that enables them to look deep within tumors and reveal their inner processes, helping them to understand the slight, frequently concealed, changes to DNA, cells, proteins, and tissue that alter the body’s healthy biochemistry and cause disease.

In research that will be presented at Frontiers in Optics (FiO), the Optical Society’s (OSA) annual meeting, to be held October 6–10, 2013, in Orlando (FL, USA), Dr. Dai Fukumura and his colleagues will present new optical imaging technology designed to track the movement of molecules, cells, and fluids within tumors; study abnormalities in the blood vessel network inside them; and observe how the tumors were affected by treatments.

These techniques, created by Dr. Fukumura and his long-term collaborators at Massachusetts General Hospital (MGH; Boston, MA, USA) and Harvard Medical School (Boston, MA, USA), combine two different high-tech optical imaging methods that were personalized for the research purposed. One approach is called multiphoton laser-scanning microscopy (MPLSM), which is a sophisticated fluorescence imaging technology that is now commercially available at the high end of the microscope market. The other is called optical frequency domain imaging (OFDI), which images tissues by their light scattering characteristics. OFDI is gaining acceptance in the optical imaging field but has not yet to become commercially available, according to Dr. Fukumura. “MPLSM overcomes many of the limitations from which conventional microscopy and confocal microscopy suffer, and OFDI provides robust large volume imaging data,” Dr. Fukumura said.

At FiO 2013, Dr. Fukumura will describe how his unique technique can image tumors completely, and show detailed pictures of live tumors—images that he and colleagues call “astonishing.” He noted that while the new integrated tool would be too costly to be used for regular diagnostic purposes, it has the potential to help scientists better figure out the obscure mechanisms of human cancer and aid in drug discovery for cancer therapy. “These optical imaging approaches can provide unprecedented insights in the biology and mechanisms of cancer,” he concluded.


Related Links:
Massachusetts General Hospital
Harvard Medical School


Channels

Genomics/Proteomics

view channel
Image: Biopsy of small bowel showing celiac disease manifested by blunting of villi, crypt hyperplasia, and lymphocyte infiltration of crypts (Photo courtesy of Wikimedia Commons).

Reduced Elafin Levels Associated with Celiac Disease Bowel Inflammation

Levels of the enzyme elafin, an endogenous serine protease inhibitor, were lower in the small intestinal epithelium of patients with active celiac disease (CD) as compared to similar tissue from control patients.... Read more

Drug Discovery

view channel

Retinoic Acid Prevents Precancerous Breast Cells from Progressing to Full-Blown Cancer

Retinoic acid, a derivative of vitamin A, was found to prevent pre-cancerous breast cells from progressing to full-blown cancer but did not have any effect on breast tumor cells. Investigators at Thomas Jefferson University (Philadelphia, PA, USA) worked with a novel breast cancer model that had been developed by treating... Read more

Biochemistry

view channel

Mitochondrial Cause of Aging Can Be Reversed

Researchers have found a cause of aging in lab animals that can be reversed, possibly providing an avenue for new treatments for age-related diseases including type 2 diabetes, cancer, muscle wasting, and inflammatory diseases. The researchers plan to begin human trials late 2014. The study, which was published December... Read more

Therapeutics

view channel

Cytokine Identified That Causes Mucositis in Cancer Therapy Patients

The action of the cytokine interleukin 1-beta (IL-1beta) has been found to underlie the onset of mucositis, a common, severe side effect of chemotherapy and irradiation of cancer patients. Mucositis occurs as a result of cell death in reaction to chemo- or radiotherapy. The mucosal lining of the mouth becomes thin, may... Read more

Business

view channel

Analytical Sciences Trade Fair Declared a Rousing Success

Organizers of this year's 24th "analytica" biosciences trade fair have reported significant increases in both the number of visitors and exhibitors compared to the 2012 event. The analytica trade fair for laboratory technology, analysis, and biotechnology has been held at the Munich (Germany) Trade Fair Center every... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.